The Bethesda System for reporting cervical cytology

Area of Science:

• Cytopathology
• Gynecologic Oncology
• Medical Diagnostics

Background:

• Papanicolaou's work laid the foundation for modern cytology reporting.
• Understanding cervical cancer pathogenesis has evolved significantly.
• Standardized reporting is crucial for consistent interpretation and patient care.

Purpose of the Study:

• To highlight The Bethesda System (TBS) as a standardized reporting format in cervicovaginal cytology.
• To emphasize the clinical relevance and evidence-based nature of TBS categories.
• To showcase TBS as an effective teaching and learning resource.

Main Methods:

• Review of the evolution and principles of The Bethesda System (TBS).
• Analysis of TBS components including specimen adequacy and categorization.
• Assessment of TBS's reproducibility, clinical relevance, and accessibility.

Main Results:

• TBS has become a universally accepted standard in cervicovaginal cytology.
• TBS reporting demonstrates high reproducibility and clinical relevance.
• TBS incorporates current scientific understanding and technological advances.

Conclusions:

• The Bethesda System (TBS) significantly enhances the understanding and management of cervical cancer.
• TBS's standardized terminology, clinical implications, and quality assurance components are key strengths.
• TBS's accessibility and educational resources have led to its widespread adoption in pathology.